Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 54 Issue 11, November 2025

Reducing pain in acute lymphoblastic leukemia models

The injection of human leukemic blast cells into immune-deficient mice is a common approach for developing preclinical models of leukemia. However, leukemia progression might be associated with pain, and efforts should be made to provide the optimal analgesic treatment for this animal model. In a new Article, Schreiber et al. demonstrate that oral administration of tramadol is more suitable than metamizole as on-demand analgesia in mouse models of acute lymphoblastic leukemia.

See Schreiber et al

Cover image: Marina Spence. Cover design: Marina Spence

Research Highlights

Top of page ⤴

News & Views

  • Recent advancements in mercury bioremediation highlight the potential of engineered organisms to transform toxic mercury into less harmful forms. Two pioneering studies demonstrate the ability of genetically modified animals and bacteria to mitigate mercury toxicity. However, these approaches face challenges, including intracellular toxicity and limited bioconversion efficiency.

    • Yan Guo
    • Chang-ye Hui
    News & Views
Top of page ⤴

Review Articles

Top of page ⤴

Articles

Top of page ⤴

Search

Quick links